scholarly journals Ibrutinib for mantle cell lymphoma at first relapse: a United Kingdom real‐world analysis of outcomes in 211 patients

2021 ◽  
Vol 193 (2) ◽  
pp. 290-298 ◽  
Author(s):  
Rory McCulloch ◽  
David Lewis ◽  
Nicola Crosbie ◽  
Toby A. Eyre ◽  
Simon Bolam ◽  
...  
Keyword(s):  
United Kingdom ◽  
Mantle Cell Lymphoma ◽  
Real World ◽  
Cell Lymphoma ◽  
Mantle Cell ◽  
First Relapse

scholarly journals Erratum on “Non-indolent mantle cell lymphoma at a single public hospital in Brazil: real world first-line treatment cohort study data”

2020 ◽  
Vol 42 (2) ◽  
pp. 194
Author(s):  
Sergio Augusto Buzian Brasil ◽  
Carolina Colaço ◽  
Tomas Barrese ◽  
Roberto P. Paes ◽  
Cristina Bortolheiro ◽  
...  
Keyword(s):  
Cohort Study ◽  
Mantle Cell Lymphoma ◽  
Real World ◽  
Public Hospital ◽  
Cell Lymphoma ◽  
Study Data ◽  
Line Treatment ◽  
First Line ◽  
Mantle Cell ◽  
First Line Treatment

scholarly journals Survival in mantle cell lymphoma after frontline treatment with Rbendamustine, R-CHOP and the Nordic MCL2 regimen – a real world study on patients diagnosed in Sweden 2007-2017

Haematologica ◽  
2021 ◽  
Author(s):  
Alexandra Albertsson-Lindblad ◽  
Thorgerdur Palsdottir ◽  
Karin E. Smedby ◽  
Caroline E. Weibull ◽  
Ingrid Glimelius ◽  
...  
Keyword(s):  
Mantle Cell Lymphoma ◽  
Real World ◽  
Cell Lymphoma ◽  
Mantle Cell ◽  
Frontline Treatment

Not available.

scholarly journals Clinical outcomes for ibrutinib in relapsed or refractory mantle cell lymphoma in real‐world experience

2019 ◽  
Vol 8 (16) ◽  
pp. 6860-6870 ◽  
Author(s):  
Young‐Woo Jeon ◽  
Seugyun Yoon ◽  
Gi June Min ◽  
Sung‐Soo Park ◽  
Silvia Park ◽  
...  
Keyword(s):  
Mantle Cell Lymphoma ◽  
Clinical Outcomes ◽  
Real World ◽  
Cell Lymphoma ◽  
Mantle Cell
Sign in / Sign up

Export Citation Format

Share Document